Golden
Breakout Ventures

Breakout Ventures

Breakout Ventures is a venture capital firm spin off of Breakout Labs specializing in investing in "hard science" companies developing products and services by combining technology, biology, materials, and energy.

Breakout ventures is a venture capital firm investing in early stage technology companies operating within and combining technologies from the sectors of technology, biology, materials, and energy. The company was founded on August 1, 2016 by Lindy Morris Fishburne, Julia Moore and Hemai Parthasarathy. Before founding Breakout Ventures, Lindy Morris Fishburne previously launched Breakout Labs alongside the Peter Thiel Foundation in October 2011. The team at Breakout Labs successfully grew the company for several years before deciding to create a more traditional venture capital firm that would later become Breakout Ventures in 2016. According to Lindy Morris Fishburne, Breakout ventures will focus on Series-A and Series-B investments in "deep science" companies.

Venture capital fund

On September 13, 2017 Breakout ventures announced it's debut venture capital fund raising $60.1 million in capital commitments.

Portfolio



Timeline

September 13, 2017

Confirmation of debut venture capital fund

Breakout Ventures announces and secures $60.1 million in venture capital commitments for it's debut venture capital fund. 

August 1, 2016

Founding of Breakout Ventures

Breakout ventures was founded on August 1, 2016 by Lindy Morris Fishburne, Julia Moore and Hemai Parthasarathy.

Funded Companies

4 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

A biotechnology company using the environmental microbiome to verify the origin of goods in global supply chains.

Cortexyme is a company developing novel treatments for Alzheimer's disease and other neurodegenerative disorders.

Immusoft is a biotechnology company developing a platform for the insertion of therapeutic genes into immune cells for the treatment of a variety of genetic diseases.

CytoVale is a company that develops biomarkers based on the mechanical properties of cells to identify diseases. It has applied its technology to detect sepsis.

People

Name
Role
LinkedIn

Partner



Partner



Managing Partner



Further reading

Title
Author
Link
Type
Date

Breakout Ventures, spun out of Peter Thiel’s Breakout Labs, has closed its debut fund with $60M

Connie Loizos

News article



These VCs Are Bringing 'Hard Science' to Fortune 500 Companies

Erin Griffith

News article



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References